Notably, highly expression of SEZ6L2 and EPHB4 were observed in stromal and epithelial cells within EM lesions, while RSPO3 exhibited increased expression in stromal cells and fibroblasts. The gene discussed is SEZ6L2; the disease is erythema multiforme.